DK3427726T3 - Ark med vedvarende lægemiddelfrigvelse til behandling af nerveskade - Google Patents
Ark med vedvarende lægemiddelfrigvelse til behandling af nerveskade Download PDFInfo
- Publication number
- DK3427726T3 DK3427726T3 DK17763162.9T DK17763162T DK3427726T3 DK 3427726 T3 DK3427726 T3 DK 3427726T3 DK 17763162 T DK17763162 T DK 17763162T DK 3427726 T3 DK3427726 T3 DK 3427726T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- drug release
- nerve injury
- release sheets
- sustained drug
- Prior art date
Links
- 208000028389 Nerve injury Diseases 0.000 title 1
- 230000008764 nerve damage Effects 0.000 title 1
- 238000013269 sustained drug release Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Psychology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016043873 | 2016-03-07 | ||
| JP2017008913 | 2017-01-20 | ||
| JP2017037270 | 2017-02-28 | ||
| PCT/JP2017/008730 WO2017154822A1 (ja) | 2016-03-07 | 2017-03-06 | 神経損傷治療用薬剤徐放シート |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3427726T3 true DK3427726T3 (da) | 2023-05-15 |
Family
ID=59789448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17763162.9T DK3427726T3 (da) | 2016-03-07 | 2017-03-06 | Ark med vedvarende lægemiddelfrigvelse til behandling af nerveskade |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US11324704B2 (da) |
| EP (1) | EP3427726B1 (da) |
| JP (2) | JP6750820B2 (da) |
| KR (1) | KR102323065B1 (da) |
| CN (2) | CN116473948A (da) |
| AU (1) | AU2017230387B9 (da) |
| CA (1) | CA3016391C (da) |
| DK (1) | DK3427726T3 (da) |
| ES (1) | ES2946262T3 (da) |
| IL (1) | IL261533B (da) |
| PL (1) | PL3427726T3 (da) |
| SG (1) | SG11201806797UA (da) |
| TW (1) | TWI790202B (da) |
| WO (1) | WO2017154822A1 (da) |
| ZA (1) | ZA201805801B (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108738345A (zh) | 2016-02-24 | 2018-11-02 | 国立大学法人大阪大学 | 试验方法 |
| WO2018056412A1 (ja) * | 2016-09-23 | 2018-03-29 | 国立大学法人大阪大学 | シュワン細胞分化促進剤及び末梢神経再生促進剤 |
| JP6650650B2 (ja) | 2017-12-21 | 2020-02-19 | 国立大学法人大阪大学 | 神経系疾患治療剤 |
| JP7391306B2 (ja) * | 2018-07-09 | 2023-12-05 | 国立研究開発法人物質・材料研究機構 | 不織布、不織布の製造方法、及び、電界紡糸用組成物 |
| JP2022517272A (ja) * | 2019-01-15 | 2022-03-07 | ユニバーシティ オブ ユタ リサーチ ファウンデーション | 薬物を送達する神経ラップ |
| KR102245629B1 (ko) * | 2019-04-10 | 2021-04-30 | 주식회사 제네웰 | 히알루론산계 녹는 필름, 이의 제조방법 및 이에 사용되는 이형지 |
| AU2021208828A1 (en) * | 2020-01-14 | 2022-07-28 | Nippon Zoki Pharmaceutical Co., Ltd. | Medical sheet |
| GB202000714D0 (en) | 2020-01-17 | 2020-03-04 | Ucl Business | Biomaterials |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60255726A (ja) * | 1984-05-31 | 1985-12-17 | Eisai Co Ltd | 消化性潰瘍治療剤 |
| US6110472A (en) * | 1992-12-10 | 2000-08-29 | Hemogen Inc. | Vitamin B12 containing scalp and skin treatment compositions |
| JPH07241433A (ja) * | 1994-03-02 | 1995-09-19 | Chiyoda Corp | 悪臭気ガスの生物処理方法及びその装置 |
| WO1998011900A2 (en) * | 1996-09-18 | 1998-03-26 | Sarill William J | Compositions containing cobalamin and amino acids |
| US20120220962A1 (en) * | 1999-12-16 | 2012-08-30 | Technology Recovery Systems, Llc | Transdermal and topical administration of vitamins using basic permeation enhancers |
| US6685956B2 (en) | 2001-05-16 | 2004-02-03 | The Research Foundation At State University Of New York | Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications |
| GB0210517D0 (en) | 2002-05-03 | 2002-06-19 | Giltech Ltd | Material |
| JP2005220070A (ja) * | 2004-02-05 | 2005-08-18 | Medgel Corp | 神経再生および保護のための生体吸収性高分子ハイドロゲル製剤 |
| EP1576952A1 (en) | 2004-03-18 | 2005-09-21 | OctoPlus Technologies B.V. | Hydrogel microspheres with improved release profile |
| WO2007089259A1 (en) * | 2006-02-02 | 2007-08-09 | The Johns Hopkins University | Therapeutic electrospun fiber compositions |
| JP2007236551A (ja) * | 2006-03-07 | 2007-09-20 | National Institute For Materials Science | キチン誘導体複合材料及び医療用材料 |
| IL183171A0 (en) * | 2007-05-14 | 2007-09-20 | Inna Rvdoy Dr | Use of vitamin b12 for treatment and prevention of mucosal lesions |
| JP2011530661A (ja) * | 2008-08-08 | 2011-12-22 | ビーエーエスエフ ソシエタス・ヨーロピア | 活性成分の制御放出を伴う有効成分含有繊維表面構造体、その使用、およびその生産のための方法 |
| TW201103448A (en) * | 2009-07-30 | 2011-02-01 | Laing Ban International Inc | Automatic cigarette maker |
| WO2011162317A1 (ja) * | 2010-06-25 | 2011-12-29 | 日本臓器製薬株式会社 | 被検物質の判定又は評価方法 |
| CN102525689B (zh) * | 2010-12-20 | 2015-06-24 | 上海市第六人民医院 | 取向纳米纤维仿生神经导管及其制作方法 |
| EP2537538A1 (en) * | 2011-06-22 | 2012-12-26 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH | Bioresorbable Wound Dressing |
| WO2013013038A2 (en) * | 2011-07-19 | 2013-01-24 | Trustees Of Boston University | Doping agents and polymeric compositions thereof for controlled drug delivery |
| EP2851095B1 (en) * | 2012-05-14 | 2021-07-14 | Teijin Limited | Sheet molding and hemostatic material |
| EP3831372A1 (en) * | 2013-01-08 | 2021-06-09 | Pathologica LLC | Mitoguazone for preventing the relapse or the progression of multiple sclerosis |
| JP5867839B2 (ja) | 2013-01-11 | 2016-02-24 | 国立研究開発法人物質・材料研究機構 | 自己発熱性及び生理活性物質放出性を有するナノファイバー、その製造方法並びに自己発熱性及び生理活性物質放出機能性不織布 |
| JP5897069B2 (ja) * | 2014-06-26 | 2016-03-30 | クリスタル・デリバリー・ビー・ブイ | 制御放出系の調製方法 |
| EP3305307A4 (en) | 2015-05-29 | 2019-02-20 | Nippon Zoki Pharmaceutical Co., Ltd. | PROMOTER OF MIGRATION OF PLURIPOTENT STEM CELLS |
-
2017
- 2017-03-06 ES ES17763162T patent/ES2946262T3/es active Active
- 2017-03-06 CN CN202310584830.2A patent/CN116473948A/zh active Pending
- 2017-03-06 WO PCT/JP2017/008730 patent/WO2017154822A1/ja active Application Filing
- 2017-03-06 JP JP2018504470A patent/JP6750820B2/ja active Active
- 2017-03-06 DK DK17763162.9T patent/DK3427726T3/da active
- 2017-03-06 AU AU2017230387A patent/AU2017230387B9/en active Active
- 2017-03-06 PL PL17763162.9T patent/PL3427726T3/pl unknown
- 2017-03-06 SG SG11201806797UA patent/SG11201806797UA/en unknown
- 2017-03-06 CN CN201780015992.7A patent/CN108883077A/zh active Pending
- 2017-03-06 CA CA3016391A patent/CA3016391C/en active Active
- 2017-03-06 KR KR1020187028337A patent/KR102323065B1/ko active IP Right Grant
- 2017-03-06 EP EP17763162.9A patent/EP3427726B1/en active Active
- 2017-03-06 US US16/082,594 patent/US11324704B2/en active Active
- 2017-03-07 TW TW106107388A patent/TWI790202B/zh active
-
2018
- 2018-08-29 ZA ZA2018/05801A patent/ZA201805801B/en unknown
- 2018-09-02 IL IL261533A patent/IL261533B/en unknown
-
2020
- 2020-07-03 JP JP2020115903A patent/JP7057573B2/ja active Active
-
2021
- 2021-02-01 US US17/163,871 patent/US12016959B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR102323065B1 (ko) | 2021-11-08 |
| EP3427726A4 (en) | 2019-10-09 |
| AU2017230387B9 (en) | 2022-08-04 |
| US20190083415A1 (en) | 2019-03-21 |
| TWI790202B (zh) | 2023-01-21 |
| JPWO2017154822A1 (ja) | 2019-04-18 |
| CA3016391A1 (en) | 2017-09-14 |
| AU2017230387A1 (en) | 2018-10-04 |
| WO2017154822A1 (ja) | 2017-09-14 |
| ES2946262T3 (es) | 2023-07-14 |
| CA3016391C (en) | 2024-06-04 |
| US12016959B2 (en) | 2024-06-25 |
| EP3427726B1 (en) | 2023-05-03 |
| JP7057573B2 (ja) | 2022-04-20 |
| CN108883077A (zh) | 2018-11-23 |
| EP3427726A1 (en) | 2019-01-16 |
| KR20180120219A (ko) | 2018-11-05 |
| ZA201805801B (en) | 2019-05-29 |
| IL261533A (en) | 2018-10-31 |
| US20210205234A1 (en) | 2021-07-08 |
| CN116473948A (zh) | 2023-07-25 |
| PL3427726T3 (pl) | 2023-07-10 |
| JP6750820B2 (ja) | 2020-09-02 |
| TW201737901A (zh) | 2017-11-01 |
| IL261533B (en) | 2021-12-01 |
| SG11201806797UA (en) | 2018-09-27 |
| AU2017230387B2 (en) | 2022-07-21 |
| US11324704B2 (en) | 2022-05-10 |
| JP2020169201A (ja) | 2020-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3427726T3 (da) | Ark med vedvarende lægemiddelfrigvelse til behandling af nerveskade | |
| CY2022039I1 (el) | Θεραπευτικες ενωσεις χρησιμες για την προφυλακτικη ή θεραπευτικη αγωγη μολυνσης ιου ηiv | |
| DK3407889T3 (da) | Organiske forbindelser og deres anvendelse til behandling og forebyggelse af lidelser i centralnervesystemet | |
| DK3212233T3 (da) | Kombinationsterapi til behandling af sygdom | |
| DK3648747T3 (da) | Gastroretentive doseringsformer til vedvarende frigivelse af lægemidler | |
| DK3448999T3 (da) | Oligonukleotider til behandling af øjensygdom | |
| DK3450553T3 (da) | Mrna-terapi til behandling af øjensygdomme | |
| DK3900742T3 (da) | Målrettet indgivelse af tertiært aminholdige lægemiddelstoffer | |
| DK3143025T3 (da) | Forbindelser til behandling af spinal muskelatrofi | |
| PT3286166T (pt) | Inibidores de replicação do vírus da imunodeficiência humana | |
| DK3240612T3 (da) | Fremgangsmåder til behandling af nethindesygdomme | |
| DK3484423T3 (da) | Anordning til hypertermisk behandling af kløe | |
| DK3116491T3 (da) | Farmaceutiske sammensætninger af terapeutisk aktive forbindelser | |
| DK3390390T3 (da) | Bipyrazolylderivater egnede til behandling af autoimmunsygdomme | |
| DK3362066T3 (da) | Kombinationsterapi til behandling af maligniteter | |
| DK3324867T3 (da) | Indretning til akut behandling af hjertestop | |
| DK3419622T3 (da) | Behandling af neurodegenerativ øjensygdom med pridopidin | |
| DK3548061T3 (da) | Behandling af neurologiske sygdomme | |
| DK3430143T3 (da) | Inhibitorer af SRSF1 til behandlingen af neurodegenerative sygdomme | |
| DK3097085T3 (da) | Benzoxazinonderivater til behandling af hudsygdomme | |
| DK3164394T3 (da) | Gls1-inhibitorer til behandling af sygdomme | |
| DK3210973T3 (da) | Heteroarylforbindelser til behandling af oftalmiske sygdomme | |
| DK3185867T3 (da) | Krystalliseringsfremgangsmåde af aripiprazolderivater i forlængede frigivelsesformuleringer til behandling af skizofreni | |
| DK3439661T3 (da) | Fremgangsmåder til behandling af øjenlidelser | |
| DK3578562T3 (da) | L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme |